Debate position: Cognition and mood are not improved in men administered exogenous testosterone therapy

Swaytha Yalamanchi, Adrian S Dobs

Research output: Contribution to journalReview article

Abstract

Purpose of review The purpose of this article is to provide an overview of the increasing evidence suggesting that exogenous testosterone therapy is not associated with improvements in cognition or mood. This article is part of a series, in this issue, in which authors are assigned opinion pieces on controversial topics pertaining to testosterone replacement. Recent findings Testosterone is increasingly being prescribed. Particularly in the setting of recent data suggestive of possible cardiovascular risk associated with its use; a clear understanding of the domains of health that improve with exogenous testosterone use is important. Data on endogenous and exogenous testosterone with cognition and mood are mixed, likely partly related to methodological differences of type of testosterone, patient population, and dosing. Summary Overall, available data are not suggestive of a clear benefit of testosterone supplementation in multiple domains of cognition and in mood. Supraphysiologic testosterone has been associated with adverse psychological outcomes, albeit not uniformly in studies.

Original languageEnglish (US)
Pages (from-to)525-531
Number of pages7
JournalCurrent Opinion in Urology
Volume27
Issue number6
DOIs
StatePublished - Nov 1 2017

Fingerprint

Cognition
Testosterone
Therapeutics
Psychology
Health
Population

Keywords

  • aggression
  • cognition
  • depression
  • mood
  • testosterone

ASJC Scopus subject areas

  • Urology

Cite this

Debate position : Cognition and mood are not improved in men administered exogenous testosterone therapy. / Yalamanchi, Swaytha; Dobs, Adrian S.

In: Current Opinion in Urology, Vol. 27, No. 6, 01.11.2017, p. 525-531.

Research output: Contribution to journalReview article

@article{c8c4f8c871cb4467991aa95cc145bf8f,
title = "Debate position: Cognition and mood are not improved in men administered exogenous testosterone therapy",
abstract = "Purpose of review The purpose of this article is to provide an overview of the increasing evidence suggesting that exogenous testosterone therapy is not associated with improvements in cognition or mood. This article is part of a series, in this issue, in which authors are assigned opinion pieces on controversial topics pertaining to testosterone replacement. Recent findings Testosterone is increasingly being prescribed. Particularly in the setting of recent data suggestive of possible cardiovascular risk associated with its use; a clear understanding of the domains of health that improve with exogenous testosterone use is important. Data on endogenous and exogenous testosterone with cognition and mood are mixed, likely partly related to methodological differences of type of testosterone, patient population, and dosing. Summary Overall, available data are not suggestive of a clear benefit of testosterone supplementation in multiple domains of cognition and in mood. Supraphysiologic testosterone has been associated with adverse psychological outcomes, albeit not uniformly in studies.",
keywords = "aggression, cognition, depression, mood, testosterone",
author = "Swaytha Yalamanchi and Dobs, {Adrian S}",
year = "2017",
month = "11",
day = "1",
doi = "10.1097/MOU.0000000000000435",
language = "English (US)",
volume = "27",
pages = "525--531",
journal = "Current Opinion in Urology",
issn = "0963-0643",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Debate position

T2 - Cognition and mood are not improved in men administered exogenous testosterone therapy

AU - Yalamanchi, Swaytha

AU - Dobs, Adrian S

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Purpose of review The purpose of this article is to provide an overview of the increasing evidence suggesting that exogenous testosterone therapy is not associated with improvements in cognition or mood. This article is part of a series, in this issue, in which authors are assigned opinion pieces on controversial topics pertaining to testosterone replacement. Recent findings Testosterone is increasingly being prescribed. Particularly in the setting of recent data suggestive of possible cardiovascular risk associated with its use; a clear understanding of the domains of health that improve with exogenous testosterone use is important. Data on endogenous and exogenous testosterone with cognition and mood are mixed, likely partly related to methodological differences of type of testosterone, patient population, and dosing. Summary Overall, available data are not suggestive of a clear benefit of testosterone supplementation in multiple domains of cognition and in mood. Supraphysiologic testosterone has been associated with adverse psychological outcomes, albeit not uniformly in studies.

AB - Purpose of review The purpose of this article is to provide an overview of the increasing evidence suggesting that exogenous testosterone therapy is not associated with improvements in cognition or mood. This article is part of a series, in this issue, in which authors are assigned opinion pieces on controversial topics pertaining to testosterone replacement. Recent findings Testosterone is increasingly being prescribed. Particularly in the setting of recent data suggestive of possible cardiovascular risk associated with its use; a clear understanding of the domains of health that improve with exogenous testosterone use is important. Data on endogenous and exogenous testosterone with cognition and mood are mixed, likely partly related to methodological differences of type of testosterone, patient population, and dosing. Summary Overall, available data are not suggestive of a clear benefit of testosterone supplementation in multiple domains of cognition and in mood. Supraphysiologic testosterone has been associated with adverse psychological outcomes, albeit not uniformly in studies.

KW - aggression

KW - cognition

KW - depression

KW - mood

KW - testosterone

UR - http://www.scopus.com/inward/record.url?scp=85030776697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030776697&partnerID=8YFLogxK

U2 - 10.1097/MOU.0000000000000435

DO - 10.1097/MOU.0000000000000435

M3 - Review article

C2 - 28863017

AN - SCOPUS:85030776697

VL - 27

SP - 525

EP - 531

JO - Current Opinion in Urology

JF - Current Opinion in Urology

SN - 0963-0643

IS - 6

ER -